PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
04-Jan-2024 Clearview Treatment Programs Certified by PsychArmor as a 'Veteran Ready' Organization AccessWire
04-Jan-2024 Pressure BioSciences’ BaroFold Platform Expected to Revolutionize Biopharmaceutical Production with Help from New Computational (AI/ML) Technologies AccessWire
04-Jan-2024 Biocomposites’ investee Renovos Biologics receives FDA Breakthrough Device Designation for its synthetic nanoclay bone fusion gel, RENOVITE® BMP-2 Biocomposites
04-Jan-2024 Anocca Secures GMP Manufacturing License To Push Novel KRAS TCR-T Cell Therapies Into Clinical Development Anocca AB
04-Jan-2024 2023 Novo Holdings Seed Investments Team Annual Review/Business Update Novo Holdings A/S
04-Jan-2024 Boehringer Ingelheim licenses multiple Dark Antigens® from Enara Bio to develop off-the-shelf immunotherapies for non-small cell lung cancer (NSCLC) Boehringer Ingelheim
04-Jan-2024 Aptar Digital Health and Gerresheimer Collaborate to Develop Integrated Solution for Subcutaneous Cancer Therapy Aptar Digital Health
04-Jan-2024 InVivo Biosystems Secures New Investment to Accelerate CRISPR Innovation InVivo Biosystems
04-Jan-2024 Lexaria's Patented Technology Improved the Oral Performance of the Rybelsus(R)-Branded GLP-1 drug Semaglutide AccessWire
04-Jan-2024 Vicore Confirms IPF Development Program on Track and Provides Early-Stage Pipeline Updates Vicore Pharma Holding AB
04-Jan-2024 The England areas with the longest distance to GP services Journo Research
04-Jan-2024 Seraxis' Manufacturing Suite Completes GMP Quality System Audit Ahead of SR-02 IND Filing and Transplantation of Pancreatic Clusters to Patients With Type 1 Diabetes AccessWire
04-Jan-2024 Newron completes enrollment of schizophrenia patients in potentially pivotal study 008A with Evenamide Newron Pharmaceuticals
04-Jan-2024 BioInvent Announces 2024 Strategic Priorities and Anticipated Milestones AccessWire
04-Jan-2024 Issuance of New US Patent Bolsters IP Protection for Jaguar Health in the Treatment of Congenital Diarrheal Disorders (CDDs) AccessWire
04-Jan-2024 Single Cell RNA Sequencing Kits Market: Trends, Innovations, and Growth Opportunities Stringent Datalytics
04-Jan-2024 Gerresheimer AG: Gerresheimer and Aptar Digital Health collaborate to develop integrated solution for cancer therapy  Gerresheimer AG
04-Jan-2024 NanoViricides to Present at the Biotech Showcase in San Fransisco AccessWire
04-Jan-2024 Zomedica Announces Publication of Research Validating Better Patient Acceptance of PulseVet(R) Electro-hydraulic Shock Wave Therapy without Sedation Utilizing Novel “X-Trode” Handpiece AccessWire
04-Jan-2024 TRYP THERAPEUTICS ANNOUNCES FIRST PATIENT DOSED IN PHASE 2a CLINICAL TRIAL FOR THE TREATMENT OF FIBROMYALGIA AT THE UNIVERSITY OF MICHIGAN Tryp Therapeutics Inc.